View Older Stories View More Recent Stories

Nov 6, 2025 05:09AM Stifel Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Hold, 'Stock Might Even Be Too Cheap, But It's Getting Harder to See the Path'
Nov 3, 2025 07:08AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered at Bernstein Amid 'Tough NT Setup'
Oct 28, 2025 09:23AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered at Truist; 'Competitive Pressures Mounting'
Oct 28, 2025 08:43AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $66 at RBC Capital
Oct 28, 2025 06:41AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $55 at H.C. Wainwright
Oct 28, 2025 06:07AM BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $73 at Stifel
Oct 28, 2025 04:58AM Wolfe on BioMarin Pharmaceutical Inc. (BMRN): 'Divesting Roctavian Is A Rock Solid Move'
Oct 27, 2025 04:08PM BioMarin Pharma (BMRN) Tops Q3 EPS by 20c
Oct 27, 2025 07:41AM Bernstein's US Biotech 3Q25 Preview: 'Expect Beats from ALNY and REGN'
Oct 14, 2025 06:50AM Cantor Fitzgerald Cuts BioMarin (BMRN) PT to $80 Ahead of 3Q Earnings
Sep 8, 2025 06:48AM H.C. Wainwright Starts BioMarin Pharmaceutical Inc. (BMRN) at Neutral
Aug 30, 2025 04:00PM Why public perception matters so much for biotech valuations
Aug 26, 2025 06:35AM Oppenheimer Reiterates Outperform Rating on BioMarin Pharmaceutical Inc. (BMRN)
Aug 19, 2025 07:08AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $95 at Bernstein SocGen Group
Aug 5, 2025 09:29AM Stifel Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)
Aug 5, 2025 09:07AM Cantor Fitzgerald Reiterates Overweight Rating on BioMarin Pharmaceutical Inc. (BMRN)
Aug 5, 2025 06:46AM Bernstein Reiterates Outperform Rating on BioMarin Pharmaceutical Inc. (BMRN)
Aug 5, 2025 06:20AM TD Cowen Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)
Aug 5, 2025 06:12AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $114 at UBS
Aug 4, 2025 04:36PM After-hours movers: Palantir, Hims & Hers, Vertex Pharma and more
Aug 4, 2025 04:04PM BioMarin Pharma (BMRN) Tops Q2 EPS by 61c ; Offers Guidance
Jul 15, 2025 06:15AM Wolfe Research Reiterates Outperform Rating on BioMarin Pharmaceutical Inc. (BMRN)
Jul 3, 2025 07:29AM Morgan Stanley Assumes BioMarin Pharmaceutical Inc. (BMRN) at Overweight
Jul 1, 2025 08:46AM BioMarin Pharma (BMRN) Announces Completion of Acquisition of Inozyme (INZY)
Jun 25, 2025 10:03AM Jefferies Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)
Jun 24, 2025 09:02AM BioMarin Pharma (BMRN) Presents Five-Year Phase 3 Results Reinforcing Long-Term Efficacy and Safety of ROCTAVIAN at International Society on Thrombosis and Haemostasis 2025 Congress
Jun 5, 2025 12:44PM FDA Cell and Gene Therapy Roundtable 'bullish for the space' - Stifel
May 27, 2025 09:44AM Stifel Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)
May 19, 2025 09:54AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised at Bernstein Following Inozyme Deal
May 16, 2025 01:11PM TD Cowen Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN) Following Inozyme Deal
May 16, 2025 12:22PM Evercore ISI on BioMarin (BMRN): 'INZY Acquisition Looks Like a Solid Addition to the Growing and Often Overlooked Enzyme Therapy Biz'
May 16, 2025 10:11AM Stifel Comments on BioMarin Pharma (BMRN): 'Acquisition of INZY A Strong Strategic Fit for BMRN; The Type of Asset That Offers Value Arbitrage'
May 16, 2025 07:31AM BioMarin Pharma (BMRN) Announces Acquisition of Inozyme Pharma (INZY) for $4 Per Share
May 12, 2025 09:06AM BioMarin Pharma (BMRN) Presents New Data for VOXZOGO in Children with Achondroplasia
May 2, 2025 10:24AM Cantor Fitzgerald Reiterates Overweight Rating on BioMarin Pharmaceutical Inc. (BMRN)
May 1, 2025 04:11PM BioMarin Pharma (BMRN) Tops Q1 EPS by 43c
Apr 21, 2025 06:46AM Oppenheimer Reiterates Outperform Rating on BioMarin Pharmaceutical Inc. (BMRN)
Apr 10, 2025 05:32AM Bernstein Recommends Three US Biotech Stocks Amid 'Heightened Regulatory Uncertainty'
Apr 2, 2025 09:06AM BioMarin Pharma (BMRN) Announces Positive Pivotal Data for PALYNZIQ in Adolescents with Phenylketonuria
Mar 20, 2025 03:57PM Citi Reiterates Neutral Rating on BioMarin Pharmaceutical Inc. (BMRN)
Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
Mar 15, 2025 04:00AM How could tariffs shake up the pharma sector?
Feb 24, 2025 04:05PM BioMarin Pharma (BMRN) Appoints Timothy P. Walbert to its Board
Feb 24, 2025 07:14AM Oppenheimer Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Outperform
Feb 20, 2025 09:05AM Cantor Fitzgerald Reiterates Overweight Rating on BioMarin Pharmaceutical Inc. (BMRN)
Feb 20, 2025 07:58AM BMO Reiterates Outperform on BioMarin Pharmaceutical Inc. (BMRN) as 'Voxzogo Growth Continues'
Feb 20, 2025 07:44AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $126 at Piper Sandler; 'Strong Execution All Around'
Feb 20, 2025 07:34AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $80 at Scotiabank
Feb 20, 2025 06:46AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $91 at Stifel
Feb 19, 2025 04:35PM After-hours movers: Carvana, Klaviyo, NerdWallet, BioMarin Pharma, and more
View More Recent Stories View Older Stories